Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Oakrum, Aucta Form Devt. & Mfg. Partnership | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Oakrum, Aucta Form Devt. & Mfg. Partnership

Relates to four oral and topical generics that will hit the U.S. market

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Oakrum Pharma has entered into an agreement with Aucta Pharmaceuticals to develop and manufacture four prescription generic pharmaceutical products that are intended to be commercialized in the U.S. under the Oakrum label. It is anticipated that the products will serve the retail market and will include oral solutions and topicals. The total addressable market for the products in the U.S. exceeded $300 million in the aggregate for the 12-month period ending December 31, 2018 according to available data from IQVIA.
 
“We are excited to partner with Aucta on our first external product development collaboration,” said Marco Polizzi, chief executive officer, Oakrum. “Aucta provides unique product development capabilities and scientific expertise that should grant Oakrum access to difficult-to-formulate products, and these products will contribute to our objective of bringing more affordable specialty and rare disease prescription products to market. These products are part of our growing pipeline of unique and high-quality affordable medicines.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics